Literature DB >> 16916709

A test of performance of breast MRI interpretation in a multicentre screening study.

Ruth Warren1, Carmel Hayes, Linda Pointon, Rebecca Hoff, Fiona J Gilbert, Anwar R Padhani, Caroline Rubin, Glenda Kaplan, Kauza Raza, Laura Wilkinson, Margaret Hall-Craggs, Preminda Kessar, Sheila Rankin, Adrian K Dixon, James Walsh, Lindsay Turnbull, Peter Britton, Ruchi Sinnatamby, Doug Easton, Deborah Thompson, Sunil R Lakhani, Martin O Leach.   

Abstract

OBJECTIVES: The aim of this study was to assess the consistency and performance of radiologists interpreting breast magnetic resonance imaging (MRI) examinations.
MATERIALS AND METHODS: Two test sets of eight cases comprising cancers, benign disease, technical problems and parenchymal enhancement were prepared from two manufacturers' equipment (X and Y) and reported by 15 radiologists using the recording form and scoring system of the UK MRI breast screening study [(MAgnetic Resonance Imaging in Breast Screening (MARIBS)]. Variations in assessments of morphology, kinetic scores and diagnosis were measured by assessing intraobserver and interobserver variability and agreement. The sensitivity and specificity of reporting performances was determined using receiver operating characteristic (ROC) curve analysis.
RESULTS: Intraobserver variation was seen in 13 (27.7%) of 47 of the radiologists' conclusions (four technical and seven pathological differences). Substantial interobserver variation was observed in the scores recorded for morphology, pattern of enhancement, quantification of enhancement and washout pattern. The overall sensitivity of breast MRI was high [88.6%, 95% confidence interval (CI) 77.4-94.7%], combined with a specificity of 69.2% (95% CI 60.5-76.7%). The sensitivities were similar for the two test sets (P=.3), but the specificity was significantly higher for the Manufacturer X dataset (P<.001). ROC curve analysis gave an area under the curve of 0.85 (95% CI 0.79-0.92)
CONCLUSIONS: Substantial variation in all elements of the scoring system and in the overall diagnostic conclusions was observed between radiologists participating in MARIBS. High overall sensitivity was achieved with moderate specificity. Manufacturer-related differences in specificities possibly occurred because the numerical thresholds set for the scoring system were not optimised for both equipment manufacturers. Scoring systems developed on one equipment software may not be transferable to other manufacturers.

Mesh:

Year:  2006        PMID: 16916709     DOI: 10.1016/j.mri.2006.03.004

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  5 in total

1.  A Metric for Reducing False Positives in the Computer-Aided Detection of Breast Cancer from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Based Screening Examinations of High-Risk Women.

Authors:  Jacob E D Levman; Cristina Gallego-Ortiz; Ellen Warner; Petrina Causer; Anne L Martel
Journal:  J Digit Imaging       Date:  2016-02       Impact factor: 4.056

2.  Semi-automatic region-of-interest segmentation based computer-aided diagnosis of mass lesions from dynamic contrast-enhanced magnetic resonance imaging based breast cancer screening.

Authors:  Jacob Levman; Ellen Warner; Petrina Causer; Anne Martel
Journal:  J Digit Imaging       Date:  2014-10       Impact factor: 4.056

3.  Effect of the enhancement threshold on the computer-aided detection of breast cancer using MRI.

Authors:  Jacob E D Levman; Petrina Causer; Ellen Warner; Anne L Martel
Journal:  Acad Radiol       Date:  2009-06-09       Impact factor: 3.173

4.  Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.

Authors:  J Hutton; L G Walker; F J Gilbert; D G Evans; R Eeles; G E Kwan-Lim; D Thompson; L J Pointon; D M Sharp; M O Leach
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

5.  Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.

Authors:  Alan Jackson; Ka-Loh Li; Xiaoping Zhu
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.